Testing will still be a critical tool against COVID-19, even as vaccines are deployed against the disease, the head of the World Health Organization (WHO) said on Friday during his regular briefing on the crisis.
COVID-19
COVID-19 Patient Shed SARS-CoV-2 Up to 70 Days
Long-term SARS-CoV-2 shedding was observed from the upper respiratory tract of a female immunocompromised patient with chronic lymphocytic leukemia and acquired hypogammaglobulinemia.
The Covid-19 pandemic has exposed the urgency for African countries to optimise public revenues from their natural resources
Because COVID-19 has overstretched the resources needed to fund essential services like education and health in Africa, the increased continental debt burden and limited inflows of aid and foreign development investment, there is pressure, more than ever to raise revenue locally.
UN report says up to 850,000 animal viruses could be caught by humans, unless we protect nature
Human damage to biodiversity is leading us into a pandemic era. The virus that causes COVID-19, for example, is linked to similar viruses in bats, which may have been passed to humans via pangolins or another species.
Novel Coronavirus Appears to hijack and exit cells as it spreads through the body – NIH findings
Researchers at the US National Institutes of Health have found out that the coronavirus deactivates the cells’ disease-fighting machinery that destroys viruses and other pathogens before they leave the cells, allowing it to freely spread throughout the body.
Remittance flows to shrink 14% by 2021 due to COVID-19
Based on the trajectory of economic activities in many large, migrant‐hosting countries, especially the United States, European countries, and the Gulf Cooperation Council (GCC) countries, remittance flows to Low- and Middle-Income Countries are expected to register a decline of 7.2 percent to $508 billion in 2020, followed by a further decline of 7.5 percent to $470 billion in 2021.
NIH RADx initiative advances six new COVID-19 testing technologies
The National Institutes of Health, working in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), today announced a third round of contract awards for scale-up and manufacturing of new COVID-19 testing technologies.
